These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries. Bisacchi D; Noonan DM; Carlone S; Albini A; Pfeffer U Biol Chem; 2002 Sep; 383(9):1315-20. PubMed ID: 12437123 [TBL] [Abstract][Full Text] [Related]
8. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. Glesby MJ; Hoover DR; Weng S; Graham NM; Phair JP; Detels R; Ho M; Saah AJ J Infect Dis; 1996 Jun; 173(6):1477-80. PubMed ID: 8648224 [TBL] [Abstract][Full Text] [Related]
13. [Successful treatment with liposomal doxorubicin and foscarnet in a patient with widespread Kaposi's sarcoma and human herpes virus 8-related, serious hemophagocytic syndrome, after renal transplantation]. Bossini N; Sandrini S; Setti G; Luppi M; Maiorca P; Maffei C; Cancarini G G Ital Nefrol; 2005; 22(3):281-6. PubMed ID: 16001371 [TBL] [Abstract][Full Text] [Related]
14. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus. Inoue N; Spira T; Lam L; Corchero JL; Luo W J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267 [TBL] [Abstract][Full Text] [Related]
15. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count. de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173 [TBL] [Abstract][Full Text] [Related]
16. Clinical progress and transmission perils stressed at second human retroviruses conference. Mascolini M J Int Assoc Physicians AIDS Care; 1995 Mar; 1(2):19-29. PubMed ID: 11362310 [TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy. Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928 [TBL] [Abstract][Full Text] [Related]
18. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals. Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020 [TBL] [Abstract][Full Text] [Related]